Agfa-Gevaert's Preliminary 2010 Results in Line with its Guidance

Agfa HealthCareThe Agfa-Gevaert Group's full year revenue amounted to 2,948 million Euro, an increase of 7.0 percent (3.2 percent excluding currency effects) compared to 2009. About half of this growth is related to Agfa Graphics' joint venture in China and the Pitman acquisition.

The Agfa-Gevaert Group's total 2010 EBIT is expected to be approximately 266 million Euro (9.0 percent of revenue), versus 182 million Euro (6.6 percent of revenue) in 2009.

The full year net result is expected to be above 100 million Euro, versus 6 million Euro in 2009.

At year end, net debt stood at 161 million Euro, compared to 445 million Euro at the end of 2009.

In spite of the uncertainties that the graphic markets faced in the fourth quarter, particularly in Europe, the revenue of the Agfa Graphics business group amounted to 1,565 million Euro. Excluding currency effects, the increase would amount to 12.2 percent.

Agfa Graphics' EBIT is expected to be about 134 million Euro (8.6 percent of revenue), compared to 63 million Euro in 2009 (4.7 percent of revenue).

Agfa HealthCare's full year revenue is almost stable at 1,180 million Euro. Excluding currency effects, a decrease of 3.3 percent would have been posted. Agfa HealthCare expects that the growth of the IT division will start to compensate for the revenue decline in the traditional business in the course of the second half of 2011.

Agfa HealthCare's EBIT is expected to amount to approximately 126 million Euro (10.7 percent of revenue), versus 116 million Euro in 2009 (9.8 percent of revenue).

The revenue of the smaller Agfa Specialty Products business group amounted to 203 million Euro, a decrease by 14.0 percent (15.4 percent excluding currency effects), mainly because of the shift of part of the film business to Agfa Graphics and the market-driven decline for some of the Classic Film products.

Agfa Specialty Products' EBIT is expected to amount to approximately 8 million Euro (3.9 percent of revenue), versus 13 million Euro in 2009 (5.5 percent of revenue).

Agfa-Gevaert's CEO Christian Reinaudo commented: "Both in terms of top line and in terms of EBIT, our 2010 results are in line with the outlook we gave in August. Driven by Agfa Graphics, we posted a revenue increase close to 200 million Euro. Both Agfa Graphics and Agfa HealthCare met their EBIT targets. So far, we only saw limited effects of the high raw material costs. The raw material related impact on the margins is expected to be more substantial as from the first quarter of this year. The effects of the recently announced price increases for our film products are expected to become more visible in the course of the second half of the year. In spite of the adverse situation on the raw material markets, we maintain - for the medium term - our average EBIT guidance."

Agfa-Gevaert will disclose its complete and fully audited 2010 results on March 25.

Related news articles:

About Agfa-Gevaert
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials).

Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe.

Most Popular Now

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Record Year with More than 800 Exhibit…

9 - 11 April 2024, Berlin, Germany. DMEA 2024 kicks off today, focusing on the key issues in the digital transformation of the healthcare system. From now until 11 April over...